https://doi.org/10.4081/monaldi.2024.2629
Gluteal muscle metastases from malignant pleural mesothelioma: a case report
Submitted: May 6, 2023
Accepted: April 19, 2024
Published: May 9, 2024
Accepted: April 19, 2024
Abstract Views: 160
PDF_EARLY VIEW: 34
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Malignant pleural mesothelioma (MPM) is a rare malignancy arising from the mesothelial or subthelial layer of the pleura, and it has increased in recent decades, mainly associated with asbestos exposure. Sarcomatoid mesothelioma is the second-most common subtype of MPM. It is usually difficult to differentiate MPM from benign mesothelial pleural proliferations or other cancers. Because of its nonspecific symptoms, MPM is often diagnosed at a late stage with distal metastases. However, it is extremely rare to see a metastatic lesion within subcutaneous tissue and muscles, which is most likely caused by hematogenous spread. We present a case of sarcomatoid mesothelioma with a metastatic lesion of the right gluteal muscles.
Micolucci L, Akhtar MM, Olivieri F, et al. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis. Oncotarget 2016;7:58606-37.
DOI: https://doi.org/10.18632/oncotarget.9686
Chen KB, Huang YJ, Huang Y, et al. Metastasis of sarcomatoid malignant mesothelioma with p16/CDKN2A deletion manifested as a subcutaneous mass in the back: a case report and review of literature. Int J Surg Pathol 2021;29:856-63.
DOI: https://doi.org/10.1177/10668969211005094
Beasley MB, Galateau-Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch 2021;478:59-72.
DOI: https://doi.org/10.1007/s00428-021-03031-7
Travis WD, Brambilla E, Nicholson AG, et al; WHO Panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10:1243-60.
DOI: https://doi.org/10.1097/JTO.0000000000000630
Alì G, Bruno R, Fontanini G. The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review. J Thorac Dis 2018;10:S276-84.
DOI: https://doi.org/10.21037/jtd.2017.10.125
Monaco S, Mehrad M, Dacic S. Recent advances in the diagnosis of malignant mesothelioma: focus on approach in challenging cases and in limited tissue and cytologic samples. Adv Anat Pathol 2018;25:24-30.
DOI: https://doi.org/10.1097/PAP.0000000000000180
Travis WD. Sarcomatoid neoplasms of the lung and pleura. Arch Pathol Lab Med 2010;134:1645-58.
DOI: https://doi.org/10.5858/2010-0086-RAR.1
Berg KB, Churg A. GATA3 immunohistochemistry for distinguishing sarcomatoid and desmoplastic mesothelioma from sarcomatoid carcinoma of the lung. Am J Surg Pathol 41:1221-5.
DOI: https://doi.org/10.1097/PAS.0000000000000825
Galetta D, Catino A, Misino A, et al. Sarcomatoid mesothelioma: future advances in diagnosis, biomolecular assessment, and therapeutic options in a poor-outcome disease. Tumori 2016;102:127-30.
DOI: https://doi.org/10.5301/tj.5000364
Ward RE, Ali SA, Kuhar M. Epithelioid malignant mesothelioma metastatic to the skin: A case report and review of the literature. J Cutan Pathol 2017;44:1057-63.
DOI: https://doi.org/10.1111/cup.13026
Kant S, Verma SK, Sanjay. Malignant pleural mesothelioma without asbestos exposure with distant metastasis in a peripheral lymph node: a case report. Lung India 2008;25:31-3.
DOI: https://doi.org/10.4103/0970-2113.44137
Zardawi SJ, Li BT, Zauderer MG, et al. Localized malignant pleural mesothelioma with renal metastasis. Oxf Med Case Reports 2015;2015:170-2.
DOI: https://doi.org/10.1093/omcr/omu064
Finn RS, Brims FJH, Gandhi A, et al. Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients. Chest 2012;142:1267-73.
DOI: https://doi.org/10.1378/chest.11-3204
Grellner W, Staak M. Multiple skeletal muscle metastases from malignant pleural mesothelioma. Pathol Res Pract 1995;191:456-62.
DOI: https://doi.org/10.1016/S0344-0338(11)80732-6
Akyurek S, Nalca Andrieu M, Hicsonmez A, et al. Skeletal muscle metastasis from malignant pleural mesothelioma. Clin Oncol (R Coll Radiol) 2004;16:585.
DOI: https://doi.org/10.1016/j.clon.2004.09.004
Kong L, Ren D, Chen S, Duan G. A case report of breast metastasis from malignant pleural mesothelioma invading the rhabdoid muscle. Asian J Surg 2023;46:2067-8.
DOI: https://doi.org/10.1016/j.asjsur.2022.11.025
How to Cite
Stirpe, Emanuele, Floriana Bardaro, and Johanna Köhl. 2024. “Gluteal Muscle Metastases from Malignant Pleural Mesothelioma: A Case Report”. Monaldi Archives for Chest Disease, May. https://doi.org/10.4081/monaldi.2024.2629.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
